Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry

BACKGROUND: Basiliximab (BSX) and antithymocyte globulins (ATGs), are two major immunosuppressive agents commonly used as induction therapy for kidney transplant (KT) recipients. The superiority of ATG over BSX has not been well established, especially in elderly KT recipients with low immunological...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jun Young, Kim, Sung Hwa, Park, Yeon Ho, Park, Jae Berm, Lee, Su Hyung, Yang, Jaeseok, Kim, Myoung Soo, Kim, Deok Gie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Nephrology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576457/
https://www.ncbi.nlm.nih.gov/pubmed/35977904
http://dx.doi.org/10.23876/j.krcp.21.310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576457/
https://www.ncbi.nlm.nih.gov/pubmed/35977904
http://dx.doi.org/10.23876/j.krcp.21.310

Ejemplares similares